In patients with obesity, semaglutide improved moderate knee osteoarthritis pain, and tirzepatide lowered the apnea–hypopnea index in moderate-to-severe obstructive sleep apnea.
In a young adult population, pharmacologic prophylaxis initiated within 24 hours was associated with lower incidence of venous thromboembolic events without increasing bleeding.